tiprankstipranks
Trending News
More News >
Oriental Aromatics Ltd. (IN:OAL)
:OAL
India Market

Oriental Aromatics Ltd. (OAL) AI Stock Analysis

Compare
0 Followers

Top Page

IN:OAL

Oriental Aromatics Ltd.

(OAL)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - 4o)
Rating:46Neutral
Price Target:
₹279.00
▼(-3.46% Downside)
Oriental Aromatics Ltd. faces significant challenges with bearish technical indicators and a high P/E ratio suggesting overvaluation. Financial performance is mixed, with strong balance sheet metrics but concerning cash flow issues. These factors contribute to a cautious outlook for the stock.
Positive Factors
Strong Balance Sheet
A low debt-to-equity ratio indicates prudent leverage management, providing financial stability and flexibility for future investments.
Improved Net Profitability
Improved net profitability suggests better cost management, which can enhance long-term earnings potential despite revenue challenges.
Return on Equity Improvement
An improving return on equity reflects enhanced profitability relative to shareholder investments, indicating efficient use of equity capital.
Negative Factors
Declining Revenue
Declining revenue growth indicates potential market challenges and could impact the company's ability to sustain long-term growth.
Cash Flow Challenges
Negative free cash flow highlights liquidity risks and the need for improved cash management, potentially affecting operational stability.
Decreased Gross Margins
Decreased gross margins suggest increased cost pressures, which could impact profitability and competitiveness in the long term.

Oriental Aromatics Ltd. (OAL) vs. iShares MSCI India ETF (INDA)

Oriental Aromatics Ltd. Business Overview & Revenue Model

Company DescriptionOriental Aromatics Limited manufactures and sells terpene chemicals, camphor, and other specialty aroma Ingredients in India. It offers specialty aroma chemicals for use in flavours, fragrances, and essential oils; synthetic camphor for medicinal and religious application; and terpineol, pine oils, astromusk, isobornyl acetate, and terpene resins. The company also provides fragrances for soaps, shampoos, hair oils, detergents, incense sticks, cosmetics and toiletries, household cleaners, air fresheners, etc.; and flavors for instant food, beverages, dairy, confectionery, oral hygiene, sweets, meat, snacks, healthcare, and bakery industries. In addition, it exports its products to Mexico, the United States, Argentina, Brazil, Colombia, France, Geneva, Germany, the Netherlands, Portugal, Spain, Switzerland, Turkey, the United Kingdom, Ukraine, Egypt, Nigeria, Bangladesh, China, Hong Kong, Indonesia, Japan, Malaysia, Myanmar, Oman, Pakistan, Singapore, Sri Lanka, Thailand, the United Arab Emirates, Vietnam, and Yemen. The company was formerly known as Camphor & Allied Products Limited and changed its name to Oriental Aromatics Limited in February 2018. Oriental Aromatics Limited was founded in 1955 and is headquartered in Mumbai, India.
How the Company Makes MoneyOriental Aromatics Ltd. generates revenue primarily through the sale of its fragrance and flavor products to a wide range of industries. Key revenue streams include direct sales of aroma chemicals and custom fragrance formulations, which are tailored to meet specific client needs. OAL also benefits from long-term partnerships with major brands in the food, beverage, and cosmetics sectors, ensuring a steady demand for its products. Additionally, the company invests in research and development to innovate and expand its product offerings, which helps attract new clients and retain existing ones. The combination of a diverse product portfolio, strategic partnerships, and a focus on innovation contributes significantly to OAL's earnings.

Oriental Aromatics Ltd. Financial Statement Overview

Summary
Oriental Aromatics Ltd. shows mixed financial performance with declining revenue and gross margins, but improved net profitability. The balance sheet remains strong with manageable debt levels and an improving return on equity. However, cash flow issues highlight liquidity risks, necessitating attention to cash management strategies.
Income Statement
Oriental Aromatics Ltd. has experienced fluctuating revenue growth with a decline of 11.8% in 2025 compared to 2024. Gross profit margins have decreased from 18.2% in 2024 to 14.4% in 2025, indicating increased cost pressures. Net profit margin improved from 1.1% to 3.7% in 2025, suggesting better cost management despite lower revenues. EBIT and EBITDA margins have also shown volatility, highlighting potential instability in operational efficiency.
Balance Sheet
The company maintains a relatively low debt-to-equity ratio of 0.53 in 2025, indicating prudent leverage management. Return on equity improved to 5.2% in 2025 from 1.4% in 2024, reflecting enhanced profitability relative to shareholder investments. The equity ratio stands at 57.9%, suggesting a balanced capital structure with moderate reliance on equity financing.
Cash Flow
The cash flow situation is concerning, with a significant decline in free cash flow from a positive position in 2024 (₹424.36 million) to a negative position in 2025 (₹-1,449.33 million). Operating cash flow to net income has turned negative, reflecting cash flow challenges despite profitability improvements. These factors indicate potential liquidity risks and the need for improved cash management.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue9.38B9.23B8.36B8.49B8.66B7.09B
Gross Profit2.06B1.30B1.52B1.62B1.89B2.36B
EBITDA912.00M966.65M534.64M543.09M969.36M1.56B
Net Income238.52M343.28M91.04M197.43M533.02M1.02B
Balance Sheet
Total Assets0.0011.45B9.95B9.86B8.65B7.45B
Cash, Cash Equivalents and Short-Term Investments111.85M111.85M111.76M181.12M77.28M182.48M
Total Debt0.003.53B2.06B2.31B1.40B787.02M
Total Liabilities-6.63B4.82B3.63B3.62B2.60B1.88B
Stockholders Equity6.63B6.63B6.32B6.25B6.05B5.57B
Cash Flow
Free Cash Flow0.00-1.45B424.36M-689.99M-603.09M-176.85M
Operating Cash Flow0.00-578.94M1.42B-223.00M-8.14M173.41M
Investing Cash Flow0.00-865.04M-989.66M-464.66M-594.42M-349.46M
Financing Cash Flow0.001.44B-482.00M781.48M514.81M156.93M

Oriental Aromatics Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price289.00
Price Trends
50DMA
311.31
Negative
100DMA
324.76
Negative
200DMA
342.52
Negative
Market Momentum
MACD
-7.82
Positive
RSI
33.46
Neutral
STOCH
14.49
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:OAL, the sentiment is Negative. The current price of 289 is below the 20-day moving average (MA) of 291.67, below the 50-day MA of 311.31, and below the 200-day MA of 342.52, indicating a bearish trend. The MACD of -7.82 indicates Positive momentum. The RSI at 33.46 is Neutral, neither overbought nor oversold. The STOCH value of 14.49 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:OAL.

Oriental Aromatics Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
₹10.92B15.250.52%28.67%50.12%
63
Neutral
₹8.42B9.430.56%-7.93%11.44%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
61
Neutral
₹11.56B15.711.47%8.06%-3.28%
47
Neutral
₹9.29B153.431.07%-22.10%-85.56%
46
Neutral
₹7.25B30.4816.43%
46
Neutral
₹9.38B95.610.17%12.25%-74.52%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:OAL
Oriental Aromatics Ltd.
278.65
-99.26
-26.27%
IN:EXCELINDUS
Excel Industries Limited
919.50
-260.58
-22.08%
IN:FAIRCHEMOR
Fairchem Organics Ltd
713.75
-227.90
-24.20%
IN:SHREEPUSHK
Shree Pushkar Chemicals & Fertilisers Ltd.
337.75
51.87
18.14%
IN:SRHHYPOLTD
Sree Rayalaseema Hi-Strength Hypo Limited
490.30
-174.35
-26.23%
IN:VALIANTORG
Valiant Organics Limited
258.70
-47.45
-15.50%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 09, 2025